Journal
CELL METABOLISM
Volume 24, Issue 5, Pages 685-700Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2016.10.011
Keywords
-
Categories
Funding
- St. Louis Ovarian Cancer Awareness Research Grant
- NIH [CA016672, CA109298, P50 CA083639, UH3 TR000943]
- American Cancer Society Research Professor Award
- Blanton-Davis Ovarian Cancer Research Program
- Frank T. McGraw Memorial Chair in Cancer Research
Ask authors/readers for more resources
Reactive stromal cells are an integral part of tumor microenvironment (TME) and interact with cancer cells to regulate their growth. Although targeting stromal cells could be a viable therapy to regulate the communication between TME and cancer cells, identification of stromal targets that make cancer cells vulnerable has remained challenging and elusive. Here, we identify a previously unrecognized mechanism whereby metabolism of reactive stromal cells is reprogrammed through an upregulated glutamine anabolic pathway. This dysfunctional stromal metabolism confers atypical metabolic flexibility and adaptive mechanisms in stromal cells, allowing them to harness carbon and nitrogen from noncanonical sources to synthesize glutamine in nutrient-deprived conditions existing in TME. Using an orthotopic mouse model for ovarian carcinoma, we find that co-targeting glutamine synthetase in stroma and glutaminase in cancer cells reduces tumor weight, nodules, and metastasis. We present a synthetic lethal approach to target tumor stroma and cancer cells simultaneously for desirable therapeutic outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available